Cargando…
Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis
HEALTH POLITICAL BACKGROUND: In developed countries 2.5% of the population - mainly children - are affected by atopic dermatitis. During the past few years its prevalence amongst school children has risen decisively and now lies between 8% to 16%. It is the most frequent chronic skin disease amongst...
Autores principales: | Fröschl, Barbara, Arts, Danielle, Leopold, Christine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011329/ https://www.ncbi.nlm.nih.gov/pubmed/21289943 |
Ejemplares similares
-
Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey
por: El Hachem, Maya, et al.
Publicado: (2017) -
Current and Emerging Therapies in Pediatric Atopic Dermatitis
por: Johnson, Hadley, et al.
Publicado: (2022) -
Cortisol Homeostasis in the Epidermis is Influenced by Topical Corticosteroids in Patients with Atopic Dermatitis
por: Fukaya, Mototsugu
Publicado: (2017) -
The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021) -
Addressing topical corticosteroid phobia in atopic dermatitis: The
role of the pharmacist
por: Ladda, Matthew, et al.
Publicado: (2021)